Vascular Diseases  >>  emiplacel (PLX-PAD)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
emiplacel (PLX-PAD) / Pluri, Charite - University of Medicine Berlin
NCT00951210: Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)

Completed
1
12
US
PLX-PAD
Pluristem Ltd.
Peripheral Artery Disease, Peripheral Vascular Disease, Critical Limb Ischemia
01/11
10/11
NCT00919958: Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia

Completed
1
15
Europe
PLX-PAD IM injection
Pluristem Ltd.
Peripheral Artery Disease, Peripheral Vascular Disease, Critical Limb Ischemia
06/12
06/12

Download Options